These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. New treatment options for acute edema attacks caused by hereditary angioedema. Thomas MC, Shah S. Am J Health Syst Pharm; 2011 Nov 15; 68(22):2129-38. PubMed ID: 22058099 [Abstract] [Full Text] [Related]
26. Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks. Hide M, Horiuchi T, Ohsawa I, Andresen I, Fukunaga A. Allergol Int; 2021 Jan 15; 70(1):45-54. PubMed ID: 32919903 [Abstract] [Full Text] [Related]
29. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert®) in a French cohort. Bouillet L, Boccon-Gibod I, Gompel A, Floccard B, Martin L, Blanchard-Delaunay C, Launay D, Fain O. Eur J Dermatol; 2017 Apr 01; 27(2):155-159. PubMed ID: 28251901 [Abstract] [Full Text] [Related]
32. Long-term Prophylaxis with Androgens in the management of Hereditary Angioedema (HAE) in emerging countries. Guo Y, Zhang H, Lai H, Wang H, Chong-Neto HJ, Valle SOR, Zhu R. Orphanet J Rare Dis; 2022 Nov 02; 17(1):399. PubMed ID: 36324138 [Abstract] [Full Text] [Related]
35. An evidence based therapeutic approach to hereditary and acquired angioedema. Bork K. Curr Opin Allergy Clin Immunol; 2014 Aug 01; 14(4):354-62. PubMed ID: 24983294 [Abstract] [Full Text] [Related]
36. Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies. Busse PJ, Farkas H, Banerji A, Lumry WR, Longhurst HJ, Sexton DJ, Riedl MA. BioDrugs; 2019 Feb 01; 33(1):33-43. PubMed ID: 30539362 [Abstract] [Full Text] [Related]
38. Current treatment of hereditary angioedema: An update on clinical studies. Banerji A. Allergy Asthma Proc; 2010 Feb 01; 31(5):398-406. PubMed ID: 20929607 [Abstract] [Full Text] [Related]